2,060
Participants
Start Date
December 1, 2022
Primary Completion Date
May 31, 2026
Study Completion Date
November 30, 2026
Intervention Arm At-risk Relative/ARR Contacts
Probands will give contact info for their ARR in the eDGP and indicate a date by which they will discuss the familial pathogenic variant with their ARR (can request a delay/halt to outreach). After this date the team will contact the ARR to invite them to review education and e-consent to the study. The study team will facilitate ARR cascade testing through telegenetics pre- and post-test counseling and saliva-based at home testing through MSK or a reference laboratory.
MyGene Portal
Through the MyGene Portal, participants will be able to continually access their genetic test results, personalized medical management recommendations from the MSK CGS care team, an interactive pedigree for personal/family history updates, and tailored educational materials for patients with a VUS in an effort to promote sustained engagement and transparency.
Standard of Care
Participants will received appropriate clinical care as outline by standard of care guidelines
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
MSK at Ralph Lauren (Limited Protocol Activities), New York
RECRUITING
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
RECRUITING
Memorial Sloan Kettering Nassau (Limited Protocol Activity), Uniondale
RECRUITING
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
RECRUITING
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
RECRUITING
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
RECRUITING
Memorial Sloan Kettering Bergen (Limited Protocol Activity), Montvale
Memorial Sloan Kettering Cancer Center
OTHER